No matter what, it's worth it
Matthew Woodruff, Emory University
 |
| A sign shows the way to a recovery area to monitor any immediate side effects from the COVID-19 vaccine on Dec. 17, 2020, in Reno, Nevada. Patrick T. Fallon /AFP via Getty Images |
You might experience redness and soreness in the arm where you got the shot, tiredness, muscle aches, chills and nausea, but these symptoms won’t last long.
You will be monitored for 15-30 minutes after you get your shot for more serious side effects, which are rare.
Side effects do not mean that you have contracted COVID-19. Vaccines work by training your immune system to recognize and remember a pathogen in a safe way.
Talk to your doctor about over-the-counter pain relievers in case you do experience flu-like symptoms after the shot, but do not take pain relievers before you get the shot.
EDITOR'S NOTE: I had almost no after-effects from the first dose of the Pfizer vaccine. About 24 hours after the second dose, I had a reaction with full body aches, headache and general malaise that felt like I was coming down with something. It went away within four hours and I felt fine the next day. And being fully vaccinated felt like a great weight had been lifted off my shoulders. - Will Collette
If you have not received your COVID-19 vaccination yet, chances are that your number is coming up soon. What can you expect when you get your shot? It’s not a day at the park for many, but others feel nothing. It’s impossible for experts to predict who’s going to feel fine and who’s not. In the vast majority of cases, any side effect you feel will be over within a few days, and there is no reason for concern.
But it is important that the medical and scientific communities talk about the temporary side effects from these vaccines – and that the public know that there is a very small percentage of adverse reactions.
I am an immunologist who studies the fundamentals of immune responses to vaccination, so part of that responsibility falls on me.
Receiving these vaccines will likely make a lot of people feel crappy for a few days. That’s a far better prospect than long-term illness or death. In case you may wonder why it makes anyone feel bad at all, I’ll explain.
Immunology’s ‘dirty little secret’
In 1989, immunologist Charles Janeway published an article summarizing the state of the field of immunology. Until that point, immunologists had proposed that immune responses were initiated when the immune system encountered anything foreign – bacteria, viruses, and parasites – that it determined to be “non-self.”
Janeway suspected that there was more to the story and famously laid out what he referred to as “the immunologist’s dirty little secret”: Your immune system doesn’t respond just to all foreign things. It responds to foreign things that it perceives to be dangerous.
Now, 30 years later, immunologists know that your immune system uses a complex set of sensors to understand not only whether or not something is foreign, but also what kind of threat, if any, a microbe might pose.
It can tell the difference between viruses – like SARS-CoV-2 – and parasites, like tapeworms, and activate specialized arms of your immune system to deal with those specific threats accordingly. It can even monitor the level of tissue damage caused by an invader and ramp up your immune response to match.
Sensing the type of threat posed by a microbe, and the level of intensity of that threat, allows your immune system to select the right set of responses, wield them precisely, and avoid the very real danger of immune overreaction.
Vaccine adjuvants bring the danger we need
Vaccines work by introducing a safe version of a pathogen to a patient’s immune system. Your immune system remembers its past encounters and responds more efficiently if it sees the same pathogen again. However, it generates memory only if the vaccine packs enough danger signals to kick off a solid immune response.
As a result, your immune system’s need to sense danger before responding is at once extremely important and highly problematic. The requirement for danger means that your immune system is programmed not to respond unless a clear threat is identified. It also means that if I’m developing a vaccine, I have to convince your immune system that the vaccine itself is a threat worth taking seriously.
Scientists can accomplish this in a number of ways. One is to inject a weakened – what immunologists call attenuated – or even killed version of a pathogen. This approach has the benefit of presenting a pathogen almost identical to the “real” pathogen, triggering many of the same danger signals and often resulting in strong long-term immunity, as is seen in polio vaccination.
It can also be risky – if you haven’t weakened the pathogen enough and roll out the vaccine too fast, there is a possibility of unintentionally infecting a large number of vaccine recipients.
A safer approach is to use individual components of the pathogen, harmless by themselves but capable of training your immune system to recognize the real thing. However, these pieces of the pathogen don’t often contain the danger signals necessary to stimulate a strong memory response. As a result, they need to be supplemented with synthetic danger signals, which immunologists refer to as “adjuvants.”
Adjuvants are safe, but designed to inflame
To make vaccines more effective, entire labs have been dedicated to the testing and development of new adjuvants. All are designed with the same basic purpose – to kick the immune system into action in a way that maximizes the effectiveness and longevity of the response.
To do this, we take advantage of the same sensors that your immune system uses to sense damage in an active infection. That means that while they will stimulate an effective immune response, they will do so by producing temporary inflammatory effects.
At a cellular level, the vaccine triggers inflammation at the injection site. Blood vessels in the area become a little more “leaky” to help recruit immune cells into the muscle tissue, causing the area to become red and swell. All of this kicks off a full-blown immune response in a lymph node somewhere nearby that will play out over the course of weeks.
In terms of symptoms, this can result in redness and swelling at the injection site, stiffness and soreness in the muscle, tenderness and swelling of the local lymph nodes and, if the vaccine is potent enough, even fever (and that associated generally crappy feeling).
This is the balance of vaccine design – maximizing protection and benefits while minimizing the uncomfortable, but necessary, side effects. That’s not to say that serious side effects don’t occur – they do – but they are exceedingly rare. Two of the most discussed serious side effects, anaphalaxis (a severe allergic reaction) and Guillain-Barré Syndrome (nerve damage due to inflammation), occur at a frequency of less than 1 in 500,000 doses.
Vaccination against SARS-CoV-2
Early data suggest that the Moderna and Pfizer mRNA vaccines against SARS-CoV-2 are highly effective – upwards of 90%. The Johnson & Johnson vaccine is also highly effective, although it was not developed using mRNA technology.
All three are capable of stimulating robust immune responses, complete with sufficient danger signaling, to prevent severe COVID-19 in greater than 9 out of 10 patients. That’s a high number under any circumstances, and suggests that these vaccines are potent.
In an early release of the phase 3 trial data, more than 2% of the Moderna vaccine recipients experienced what they categorized as severe temporary side effects, such as fatigue and headache. However, more mild side effects are common – particularly after the second dose.
These are signs that the vaccine is doing what it was designed to do – train your immune system to respond against something it might otherwise ignore so that you’ll be protected later. It does not mean that the vaccine gave you COVID-19.
It all comes down to this: By getting vaccinated, you protect yourself, your loved ones and your community from a highly transmissible and deadly disease. It may cost you a few days of feeling sick.
Editor’s Note: This article is updated from a previous version, which was published originally Dec. 3, 2020.
Matthew Woodruff, Instructor, Lowance Center for Human Immunology, Emory University
This article is republished from The Conversation under a Creative Commons license. Read the original article.
[Research into coronavirus and other news from science Subscribe to The Conversation’s new science newsletter.]
